| scholarly article | Q13442814 |
| P50 | author | Joyann Marks | Q83401499 |
| DaShawn A Hickman | Q59149129 | ||
| P2093 | author name string | Anirban Sen Gupta | |
| Christa L Pawlowski | |||
| Ujjal D S Sekhon | |||
| P2860 | cites work | Tourniquets: another adjunct in damage control? | Q83078273 |
| A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery | Q83222010 | ||
| Pressure applied by the emergency/Israeli bandage | Q83347551 | ||
| A highly porous silica and chitosan-based hemostatic dressing is superior in controlling hemorrhage in a severe groin injury model in swine | Q83730608 | ||
| Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro | Q83790128 | ||
| Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage | Q83937026 | ||
| Alginate based bilayer hydrocolloid films as potential slow-release modern wound dressing | Q84240017 | ||
| Comparison of 10 hemostatic dressings in a groin puncture model in swine | Q84450618 | ||
| Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine | Q84536255 | ||
| Late wound healing problems after use of BioGlue for apical hemostasis during transapical aortic valve implantation | Q84637281 | ||
| Fibrinogen concentrate for management of bleeding | Q85193685 | ||
| In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct | Q85982195 | ||
| Comparison of novel hemostatic dressings with QuikClot combat gauze in a standardized swine model of uncontrolled hemorrhage | Q87143950 | ||
| Gauze vs XSTAT in wound packing for hemorrhage control | Q87229989 | ||
| Damage control resuscitation | Q89284996 | ||
| Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation | Q22254871 | ||
| Integrin ligands at a glance | Q24600618 | ||
| Isolation and characterization of a cDNA coding for human factor IX | Q24629231 | ||
| Advances and Challenges of Liposome Assisted Drug Delivery | Q26773160 | ||
| Infusible platelet membrane as a platelet substitute for transfusion: an overview | Q26861577 | ||
| Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation | Q26865798 | ||
| Design strategies and applications of tissue bioadhesives | Q27027398 | ||
| A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis | Q27327667 | ||
| Self-propelled particles that transport cargo through flowing blood and halt hemorrhage | Q27340130 | ||
| Applying results from clinical trials: tranexamic acid in trauma patients | Q28082587 | ||
| Damage control resuscitation | Q28083607 | ||
| Exposure of platelet membrane phosphatidylserine regulates blood coagulation | Q28180138 | ||
| The use of desmopressin as a hemostatic agent: a concise review | Q28210194 | ||
| Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms | Q28215367 | ||
| Surface exposure of phosphatidylserine in pathological cells | Q28239340 | ||
| Molecular cloning of a cDNA encoding human antihaemophilic factor | Q28268498 | ||
| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 | ||
| Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma | Q28296612 | ||
| Transfusion medicine. First of two parts--blood transfusion | Q28296931 | ||
| A hundred years of cascading - started by Paul Morawitz (1879-1936), a pioneer of haemostasis and of transfusion | Q28297562 | ||
| Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells | Q28303798 | ||
| Characterization of a cDNA coding for human factor VII | Q28646329 | ||
| Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin | Q28647081 | ||
| Finite platelet size could be responsible for platelet margination effect | Q35342189 | ||
| Collagens—structure, function, and biosynthesis | Q35586683 | ||
| Recombinant collagen and gelatin for drug delivery | Q35586686 | ||
| A comparison of antifibrinolytic agents used in hemostatic fibrin sealants | Q35595989 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| The adhesion molecule P-selectin and cardiovascular disease | Q35601863 | ||
| Dosing with recombinant factor viia based on current evidence | Q35661486 | ||
| The application of recombinant human collagen in tissue engineering | Q35717071 | ||
| The role of collagen in thrombosis and hemostasis | Q35752946 | ||
| P-selectin in haemostasis | Q35838444 | ||
| Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding | Q35839531 | ||
| Recombinant biologics for treatment of bleeding disorders | Q35852300 | ||
| Platelet physiology and thrombosis. | Q35928709 | ||
| The mechanical properties of fibrin for basic scientists and clinicians | Q35967997 | ||
| Hemostatic agents | Q35976539 | ||
| Polyphosphate: a link between platelets, coagulation and inflammation | Q35991866 | ||
| Hemorrhage control in the battlefield: role of new hemostatic agents | Q36051228 | ||
| 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. | Q36068943 | ||
| Clotting Mimicry from Robust Hemostatic Bandages Based on Self-Assembling Peptides | Q36087858 | ||
| Interactions of platelets with subendothelium and endothelium | Q36090987 | ||
| Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps | Q36215702 | ||
| The promise and challenges of bioengineered recombinant clotting factors | Q36230850 | ||
| Fibrinogen and fibrin structure and functions | Q36230901 | ||
| Glycosylation and cold platelet storage. | Q36289631 | ||
| Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. | Q36327671 | ||
| Shock and hemorrhage: an overview of animal models | Q36351630 | ||
| Platelet mimetic particles for targeting thrombi in flowing blood | Q36355586 | ||
| Compressive optic neuropathy after use of oxidized regenerated cellulose in orbital surgery: review of complications, prophylaxis, and treatment | Q36365815 | ||
| Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles | Q36411350 | ||
| Making sense of the preclinical literature on advanced hemostatic products | Q36419206 | ||
| Molecular mechanisms of RADA16-1 peptide on fast stop bleeding in rat models | Q36432615 | ||
| A cell-based model of thrombin generation | Q36467885 | ||
| Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations | Q36501096 | ||
| Embolization agents-which one should be used when? Part 2: small-vessel embolization | Q41775496 | ||
| The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia | Q41787633 | ||
| Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot | Q41825512 | ||
| A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets | Q41966601 | ||
| Autoactivation of human recombinant coagulation factor VII. | Q42193518 | ||
| A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial | Q42646517 | ||
| Development of a chitosan-based biofoam: application to the processing of a porous ceramic material | Q42723069 | ||
| Hemostasis for severe hemorrhage with photocrosslinkable chitosan hydrogel and calcium alginate | Q42975263 | ||
| Effects of arterial blood pressure on rebleeding using Celox and TraumaDEX in a porcine model of lethal femoral injury. | Q43007922 | ||
| Electrokinetic and hemostatic profiles of nonwoven cellulosic/synthetic fiber blends with unbleached cotton | Q43093100 | ||
| Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine | Q43162465 | ||
| Pathogen reduction technology (Mirasol) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS. | Q43269326 | ||
| Evaluation of the toxicity of onyx compared with n-butyl 2-cyanoacrylate in the subarachnoid space of a rabbit model: an experimental research | Q43276165 | ||
| The use of Onyx for embolization of central nervous system arteriovenous lesions in pediatric patients | Q43277430 | ||
| A rapidly resorbable hemostatic biomaterial based on dihydroxyacetone | Q43298908 | ||
| Survival with emergency tourniquet use to stop bleeding in major limb trauma. | Q43423147 | ||
| Mussel-inspired hyperbranched poly(amino ester) polymer as strong wet tissue adhesive | Q43485266 | ||
| Hemostasis in a noncompressible hemorrhage model: an end-user evaluation of hemostatic agents in a proximal arterial injury | Q43506556 | ||
| Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. | Q43647984 | ||
| Use of absorbable cyanoacrylate glue to repair an open cystotomy | Q43931639 | ||
| Blood protein adsorption onto chitosan | Q44008294 | ||
| Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions | Q44100697 | ||
| Stabilization of gelatin films by crosslinking with genipin | Q44166189 | ||
| Ostene, a new water-soluble bone hemostasis agent | Q44214741 | ||
| Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants | Q44247288 | ||
| A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis | Q44360166 | ||
| Epsilon-amino caproic acid additive decreases fibrin bandage performance in a swine arterial bleeding model | Q44390770 | ||
| Microcrystalline collagen. A new hemostatic agent | Q44460080 | ||
| Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). | Q44645544 | ||
| Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery | Q44685521 | ||
| Recombinant factor VIIa in trauma patients with the 'triad of death'. | Q44732850 | ||
| Experimental and clinical applications of fibrin glue | Q44742229 | ||
| Use of absorbable collagen for hemostasis in general surgical patients | Q44779044 | ||
| Biodegradation of oxidized regenerated cellulose | Q44805206 | ||
| Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage | Q44931496 | ||
| Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent | Q44997920 | ||
| Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models | Q44997932 | ||
| The US military experience with fresh whole blood during the conflicts in Iraq and Afghanistan | Q45028730 | ||
| The safety of fibrin sealants | Q45095482 | ||
| Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. | Q45103688 | ||
| Modified rapid deployment hemostat bandage reduces blood loss and mortality in coagulopathic pigs with severe liver injury | Q45234052 | ||
| The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation | Q45868522 | ||
| Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group | Q45874565 | ||
| Mechanism of factor VIIa-dependent coagulation in hemophilia blood | Q45882859 | ||
| Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. | Q45902625 | ||
| Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. | Q45967882 | ||
| Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma. | Q46010239 | ||
| Fibrinogen replacement in trauma haemorrhage. | Q46015066 | ||
| Host-guest composites for induced hemostasis and therapeutic healing in traumatic injuries | Q46043710 | ||
| Intracorporeal use of advanced local hemostatics in a damage control swine model of grade IV liver injury | Q46173100 | ||
| Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery | Q46180325 | ||
| A tissue sealant based on reactive multifunctional polyethylene glycol | Q46219349 | ||
| An injectable shear-thinning biomaterial for endovascular embolization. | Q51098847 | ||
| Prophylactic gelatin sponge tract injection to prevent bleeding after percutaneous renal cryoablation in a swine model. | Q51130192 | ||
| Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering. | Q51143269 | ||
| Use of a hydrogel dressing for management of a painful leg ulcer. | Q51165341 | ||
| Transglutaminase reactivity with gelatine: perspective applications in tissue engineering. | Q51175307 | ||
| A special report on the chitosan-based hemostatic dressing: experience in current combat operations. | Q51249127 | ||
| Nanoparticle-assisted visualization of binding interactions between collagen mimetic peptide and collagen fibers. | Q51255336 | ||
| Controlled survival study of the effects of Tisseel or a combination of FloSeal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. | Q51322329 | ||
| Effectiveness of self-applied tourniquets in human volunteers. | Q51326844 | ||
| In-vitro hemocompatibility evaluation of a thermoplastic polyurethane membrane with surface-immobilized water-soluble chitosan and heparin. | Q51342296 | ||
| A salmon thrombin-fibrin bandage controls arterial bleeding in a swine aortotomy model. | Q51372713 | ||
| Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury. | Q51496493 | ||
| Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. | Q51531296 | ||
| Oxidized regenerated cellulose gauze for hemostasis of a two-stage interpolation flap pedicle. | Q51565005 | ||
| Modified rapid deployment hemostat bandage terminates bleeding in coagulopathic patients with severe visceral injuries. | Q51591563 | ||
| Mussel-inspired soft-tissue adhesive based on poly(diol citrate) with catechol functionality. | Q51592011 | ||
| Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. | Q51607720 | ||
| Thermal injury resulting from application of a granular mineral hemostatic agent. | Q51623581 | ||
| FloSeal Matrix: new generation topical hemostatic sealant. | Q51707444 | ||
| Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. | Q51724353 | ||
| Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. | Q51759013 | ||
| Topical haemostatics in renal trauma--an evaluation of four different substances in an experimental setting. | Q51774294 | ||
| Central renal stab wounds: treatment with augmented fibrin sealant in a porcine model. | Q51787387 | ||
| FVII dependent coagulation activation in citrated plasma by polymer hydrogels. | Q53451808 | ||
| Effect of cold storage on shear-induced platelet aggregation and clot strength. | Q53464217 | ||
| Surgicel Nu-Knit hemostat for bleeding control of fragile sternum. | Q53879868 | ||
| The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. | Q55035491 | ||
| Recombinant clotting factors. | Q55049788 | ||
| Allogeneic transfusion risks in the surgical patient. | Q55240662 | ||
| Die Chemie der Blutgerinnung | Q56169071 | ||
| Hemostatic complexes based on polyacrylic acid | Q57351396 | ||
| Hemostatic polymers: the concept, state of the art and perspectives | Q57376754 | ||
| ABSORBABLE COTTON, PAPER AND GAUZE : (OXIDIZED CELLULOSE) | Q57656433 | ||
| Efficacy of Three Topical Hemostatic Agents Applied by Medics in a Lethal Groin Injury Model | Q57979033 | ||
| The global burden of injuries | Q58024276 | ||
| Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial | Q64126613 | ||
| Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex | Q68506495 | ||
| In vivo degradation of oxidized, regenerated cellulose | Q68872653 | ||
| Tissue response to a haemostatic alginate wound dressing in tooth extraction sockets | Q70764939 | ||
| Experimental and Clinical Experiences with Collagen Fleece as a Hemostatic Agent | Q70768395 | ||
| The presence and release of alpha 2-antiplasmin from human platelets | Q70997782 | ||
| Collagen fibers as a fleece hemostatic agent | Q71272024 | ||
| Microcrystalline collagen as a biologic dressing, vascular prosthesis, and hemostatic agent | Q71327788 | ||
| Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia | Q71493148 | ||
| The structural properties and contractile force of a clot | Q71845050 | ||
| Alginate fiber dressing for oral mucosal wounds | Q72054982 | ||
| Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations | Q72114715 | ||
| Efficacy of a fibrin hemostatic bandage in controlling hemorrhage from experimental arterial injuries | Q72141614 | ||
| Treatment of suture line bleeding with a novel synthetic surgical sealant in a canine iliac PTFE graft model | Q46258295 | ||
| Metal oxide surface charge mediated hemostasis | Q46277929 | ||
| Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization | Q46278209 | ||
| Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). | Q46325488 | ||
| Fibrin glue-oxidized cellulose sandwich for laparoscopic wedge resection of small renal lesions | Q46430828 | ||
| Development of a resorbable macroporous cellulosic material used as hemostatic in an osseous environment | Q46478864 | ||
| Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin | Q46512414 | ||
| Recommendation for appropriate use of GRF glue in the operation for acute aortic dissection. | Q46643128 | ||
| Haemostatic efficacy of an ethyl-2-cyanoacrylate-based aerosol in combination with tourniquet application in a large wound model with an arterial injury | Q46836242 | ||
| The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions | Q46855022 | ||
| Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists | Q46933788 | ||
| Development of a recombinant human collagen-type III based hemostat | Q46969574 | ||
| Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ib alpha to size-controlled albumin microspheres | Q47198865 | ||
| The combination of platelet-enriched autologous plasma with bovine collagen and thrombin decreases the need for multiple blood transfusions in trauma patients with retroperitoneal bleeding | Q47234781 | ||
| A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges | Q47301383 | ||
| Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product | Q47336115 | ||
| Exothermic reaction in zeolite hemostatic dressings: QuikClot ACS and ACS+. | Q47392737 | ||
| Fibrin sealant produced by the CryoSeal FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting. | Q47602461 | ||
| Comparative evaluation of absorbable hemostats: advantages of fibrin-based sheets | Q47606630 | ||
| Evaluation of techniques for treating the bleeding wound | Q47630117 | ||
| Collagen--biomaterial for drug delivery | Q47684760 | ||
| Comparison of a new mineral based hemostatic agent to a commercially available granular zeolite agent for hemostasis in a swine model of lethal extremity arterial hemorrhage | Q47701878 | ||
| Structural biology of glycoprotein IIb-IIIa | Q47772956 | ||
| Micro-scale dynamic simulation of erythrocyte-platelet interaction in blood flow | Q47856475 | ||
| Gelatin thrombin granules for hemostasis in a severe traumatic liver and spleen rupture model in swine | Q47887649 | ||
| A novel biologic hemostatic dressing (fibrin patch) reduces blood loss and resuscitation volume and improves survival in hypothermic, coagulopathic Swine with grade V liver injury | Q47982091 | ||
| Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage | Q48019395 | ||
| Comparative efficacy of granular and bagged formulations of the hemostatic agent QuikClot | Q48019403 | ||
| The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model | Q48091381 | ||
| How I use fibrinogen replacement therapy in acquired bleeding | Q48244071 | ||
| Hydrophobically-modified chitosan foam: description and hemostatic efficacy | Q48255717 | ||
| Effects of Celox and TraumaDEX on hemorrhage control in a porcine model. | Q48348315 | ||
| Self-expanding foam for prehospital treatment of severe intra-abdominal hemorrhage: dose finding study | Q48348669 | ||
| Self-expanding polyurethane polymer improves survival in a model of noncompressible massive abdominal hemorrhage | Q48471983 | ||
| A pre-hospital technique for controlling haemorrhage from traumatic perineal and high amputation injuries | Q48485113 | ||
| Comparative evaluation of avitene microcrystalline collagen hemostat in experimental animal wounds | Q48677968 | ||
| Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan | Q48818438 | ||
| Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor | Q50132660 | ||
| Tachocomb used in endoscopic surgery. | Q50165690 | ||
| Platelet activation and blood coagulation. | Q50281720 | ||
| Feasibility and transport of packed red blood cells into Special Forces operational conditions. | Q50475985 | ||
| Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. | Q50758503 | ||
| A review of the therapeutic uses of thrombin. | Q50889083 | ||
| Surgicel: its fate following implantation. | Q50919759 | ||
| Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. | Q50949229 | ||
| High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage. | Q50973950 | ||
| Chitosan dressing provides hemostasis in swine femoral arterial injury model. | Q51019285 | ||
| The potential utility of fibrin sealant dressing in repair of vascular injury in swine. | Q51084940 | ||
| Chitosan: A New Hemostatic | Q72787105 | ||
| Comparative in vitro analysis of topical hemostatic agents | Q73048839 | ||
| Chitosan enhances platelet adhesion and aggregation | Q73074228 | ||
| Intraoperative use of the absorbable fibrin adhesive bandage: long term effects | Q73091258 | ||
| Pneumostatic effect of gelatin-resorcinol formaldehyde-glutaraldehyde glue on thermal injury of the lung: an experimental study on rats | Q73175445 | ||
| Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints | Q73327099 | ||
| Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin | Q73352712 | ||
| Purification of salmon clotting factors and their use as tissue sealants | Q73385006 | ||
| Treatment of grade 4 renal stab wounds with absorbable fibrin adhesive bandage in a porcine model | Q73436792 | ||
| Tourniquets for hemorrhage control on the battlefield: a 4-year accumulated experience | Q73439112 | ||
| Recombinant factor IX | Q73447386 | ||
| Hemostatic efficacy of a fibrin sealant-based topical agent in a femoral artery injury model: a randomized, blinded, placebo-controlled study | Q73651801 | ||
| Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine | Q73659115 | ||
| Lyophilized platelets: continued development | Q73689865 | ||
| Bleeding from the sternal marrow can be stopped using vivostat patient-derived fibrin sealant | Q73759593 | ||
| Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release | Q73850109 | ||
| Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy | Q73883494 | ||
| Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators | Q73925075 | ||
| Efficacy of a dry fibrin sealant dressing for hemorrhage control after ballistic injury | Q74076197 | ||
| Comparative study of the hemostatic efficacy of a new human fibrin sealant: is an antifibrinolytic agent necessary? | Q74230551 | ||
| The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation | Q74284028 | ||
| Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions | Q74314265 | ||
| Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction | Q74332512 | ||
| Development of an animal model for assessment of the hemostatic efficacy of fibrin sealant in vascular surgery | Q74409121 | ||
| The action of some water-soluble poly-alpha-amino acids on fibrinolysis | Q76247936 | ||
| Potential uses of absorbable fibrin adhesive bandage for genitourinary trauma | Q77443942 | ||
| Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures | Q77748589 | ||
| A histological comparison of acute inflammatory responses with a hydrofibre or tulle gauze dressing | Q77882276 | ||
| Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives | Q77925242 | ||
| Effect of dry fibrin sealant dressings versus gauze packing on blood loss in grade V liver injuries in resuscitated swine | Q77950786 | ||
| Evaluation of application techniques of fibrin sealant to prevent cerebrospinal fluid leakage: a new device for the application of aerosolized fibrin glue | Q77951598 | ||
| An investigation of the chemical reactions of oxidized regenerated cellulose | Q79019260 | ||
| FDA approach to evaluation of pathogen reduction technology | Q79079817 | ||
| Hemostatic properties of glucosamine-based materials | Q79139105 | ||
| New generation tissue sealants and hemostatic agents: innovative urologic applications | Q79251701 | ||
| Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study | Q79396207 | ||
| A case series describing thermal injury resulting from zeolite use for hemorrhage control in combat operations | Q79434101 | ||
| Absorbable haemostatics, their uses and identification | Q79577740 | ||
| Rational design of antithrombotic peptides to target the von Willebrand factor (vWf)--GPIb integrin interaction | Q79614699 | ||
| Wound-healing properties of trehalose-stabilized freeze-dried outdated platelets | Q80025443 | ||
| Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain | Q80273707 | ||
| Application of novel hemostatic agent during laparoscopic partial nephrectomy | Q80352738 | ||
| Nanoparticles that display short collagen-related peptides. Potent stimulation of human platelet aggregation by triple helical motifs | Q80510975 | ||
| Surface properties and in vitro analyses of immobilized chitosan onto polypropylene non-woven fabric surface using antenna-coupling microwave plasma | Q80528552 | ||
| RGD and other recognition sequences for integrins | Q29616331 | ||
| Hemostatic effect of Vivostat patient-derived fibrin sealant on split-thickness skin graft donor sites | Q30310725 | ||
| Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective | Q30413860 | ||
| Injectable citrate-based mussel-inspired tissue bioadhesives with high wet strength for sutureless wound closure | Q30416501 | ||
| A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs | Q30430562 | ||
| Fibrin sealant: past, present, and future: a brief review | Q30449208 | ||
| Intravenously administered nanoparticles increase survival following blast trauma | Q30584438 | ||
| Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen: approach to platelet substitutes | Q30798763 | ||
| Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial | Q30877676 | ||
| Cytotoxicity, blood compatibility and antimicrobial activity of two cyanoacrylate glues for surgical use. | Q31581624 | ||
| Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex | Q31974821 | ||
| Use of poly(2-hydroxyethyl methacrylate) for endovascular occlusion in pediatric surgery | Q33328375 | ||
| Pharmacologic treatment options in patients with thrombocytopenia | Q33332598 | ||
| Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions | Q33334113 | ||
| Novel platelet products, substitutes and alternatives | Q33338494 | ||
| Novel treatment modalities: new platelet preparations and substitutes | Q33338937 | ||
| Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions | Q33340486 | ||
| Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage | Q33341446 | ||
| Substitutes and alternatives to platelet transfusions in thrombocytopenic patients | Q33349074 | ||
| Function of fibrinogen gamma-chain dodecapeptide-conjugated latex beads under flow | Q33358243 | ||
| Recombinant factor VIIa in the treatment of bleeding | Q33358762 | ||
| Optimizing platelet transfusion therapy | Q33361167 | ||
| Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia | Q33365111 | ||
| Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo | Q33367016 | ||
| Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo | Q33369240 | ||
| New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions | Q33373596 | ||
| Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide | Q33375630 | ||
| Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits | Q33380183 | ||
| Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute | Q33382776 | ||
| Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
| Platelet transfusion: a clinical practice guideline from the AABB. | Q33418628 | ||
| Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions | Q33436810 | ||
| In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice | Q33437439 | ||
| A liposome based platelet substitute, the plateletsome, with hemostatic efficacy | Q33493616 | ||
| Intravenous hemostats: challenges in translation to patients | Q38148673 | ||
| Natural and synthetic polymers for wounds and burns dressing. | Q38173788 | ||
| Ex vivo production of platelets from stem cells | Q38187494 | ||
| Acute traumatic coagulopathy: clinical characterization and mechanistic investigation | Q38206636 | ||
| Thrombin production and human neutrophil elastase sequestration by modified cellulosic dressings and their electrokinetic analysis | Q38222531 | ||
| Clinical experience with the surgicel family of absorbable hemostats (oxidized regenerated cellulose) in neurosurgical applications: a review | Q38418097 | ||
| Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature | Q38573793 | ||
| Fibrinolysis in Trauma: "Myth," "Reality," or "Something in Between". | Q38755236 | ||
| Clotting activity of polyphosphate-functionalized silica nanoparticles. | Q38845465 | ||
| Alginate-calcium microsphere loaded with thrombin: a new composite biomaterial for hemostatic embolization | Q38920576 | ||
| Fast in situ generated ɛ-polylysine-poly (ethylene glycol) hydrogels as tissue adhesives and hemostatic materials using an enzyme-catalyzed method | Q38950676 | ||
| Zeolite-based hemostat QuikClot releases calcium into blood and promotes blood coagulation in vitro | Q39014379 | ||
| Ultrasoft microgels displaying emergent platelet-like behaviours. | Q39133739 | ||
| Rapidly in situ forming chitosan/ε-polylysine hydrogels for adhesive sealants and hemostatic materials | Q39149704 | ||
| Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine | Q39307794 | ||
| Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine | Q39379993 | ||
| A porcine model for evaluating the management of noncompressible torso hemorrhage. | Q39721855 | ||
| Mechanics and contraction dynamics of single platelets and implications for clot stiffening | Q39756732 | ||
| Human plasma proteinase inhibitors | Q40107740 | ||
| Temperature and pH effects on biophysical and morphological properties of self-assembling peptide RADA16-I. | Q40134145 | ||
| The use of a surgical sealant (CoSeal) in cardiac and vascular reconstructive surgery: an economic analysis. | Q40338525 | ||
| Glycosylation restores survival of chilled blood platelets | Q40635116 | ||
| Elastic adhesive dressing treatment of bleeding wounds in trauma victims | Q40736066 | ||
| Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats | Q40750768 | ||
| Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications | Q40896839 | ||
| Intravenous hemostat: nanotechnology to halt bleeding. | Q41470605 | ||
| The proper use of glue: a 20-year experience with the GRF glue in acute aortic dissection. | Q41577678 | ||
| A sprayable hemostat containing fibrillar collagen, bovine thrombin, and autologous plasma | Q41688775 | ||
| Enzyme-controlling medicines: introduction | Q41704165 | ||
| Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets | Q33496016 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| Current concepts in platelet transfusion | Q33560053 | ||
| Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue | Q33565224 | ||
| Present status of gelatin sponge for the control of hemorrhage; with experimental data on its use for wounds of the great vessels and the heart | Q33730999 | ||
| A porcine epistaxis model: hemostatic effects of octylcyanoacrylate | Q33978225 | ||
| Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials | Q34132303 | ||
| Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging | Q34134243 | ||
| In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis | Q34170404 | ||
| Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine | Q34172504 | ||
| Platelet bioreactor-on-a-chip | Q34209300 | ||
| Alginate: properties and biomedical applications | Q34236679 | ||
| AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Fibrinogen: structure, function, and surface interactions | Q34271300 | ||
| Remodeling the blood coagulation cascade | Q34294608 | ||
| Polyphosphate modulates blood coagulation and fibrinolysis. | Q34304738 | ||
| Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time--comparison of strength with commercial fibrin glue | Q34317150 | ||
| Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. | Q34340830 | ||
| A novel sponge-based wound stasis dressing to treat lethal noncompressible hemorrhage. | Q34357198 | ||
| Fibrin sealants in surgical practice: An overview | Q34376135 | ||
| Shear-thinning nanocomposite hydrogels for the treatment of hemorrhage | Q34419933 | ||
| Recombinant factor VIIa (Novoseven) and the safety of treatment | Q34458120 | ||
| Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries | Q34579964 | ||
| Alginate dressings in surgery and wound management--Part 1. | Q34587710 | ||
| Haemophilia 2002: emerging risks of treatment | Q34636927 | ||
| Surgical Materials: Current Challenges and Nano-enabled Solutions. | Q34706866 | ||
| Experience with chitosan dressings in a civilian EMS system | Q34714864 | ||
| Production of pharmaceutical proteins by transgenic animals | Q34744705 | ||
| QuikClot use in trauma for hemorrhage control: case series of 103 documented uses | Q34769195 | ||
| Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature | Q34867430 | ||
| Trauma-Induced Coagulopathy | Q34889509 | ||
| Fibrinolysis and the control of blood coagulation | Q35039847 | ||
| Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time | Q35064119 | ||
| PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage. | Q36505721 | ||
| Fresh whole blood transfusion: a controversial military practice | Q36532895 | ||
| Asymmetric distribution of phospholipids in biomembranes | Q36553001 | ||
| Haemostasis | Q36604077 | ||
| Pathogen-reduction systems for blood components: the current position and future trends | Q36655451 | ||
| Lyophilized platelets: fifty years in the making | Q36761369 | ||
| Adhesion mechanisms in platelet function | Q36856340 | ||
| Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model | Q36887203 | ||
| Nanoparticle biointerfacing by platelet membrane cloaking | Q36912680 | ||
| Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent | Q36931821 | ||
| Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital | Q36935272 | ||
| Cell adhesion mechanisms in platelets | Q37049884 | ||
| Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents | Q37085877 | ||
| Anticancer Platelet-Mimicking Nanovehicles. | Q37206537 | ||
| Pathogen reduction of blood components | Q37207560 | ||
| Recommendations for the transfusion of plasma and platelets | Q37209117 | ||
| The coagulopathy of trauma: a review of mechanisms | Q37292306 | ||
| A review of three stand-alone topical thrombins for surgical hemostasis. | Q37401469 | ||
| The long term immunological response of swine after two exposures to a salmon thrombin and fibrinogen hemostatic bandage | Q37595526 | ||
| Molecular structure of RADA16-I designer self-assembling peptide nanofibers | Q37624430 | ||
| Hemostatic function of apheresis platelets stored at 4°C and 22°C. | Q37710229 | ||
| First 20 years with recombinant FVIIa (NovoSeven). | Q37770599 | ||
| Role of fibrinogen in trauma-induced coagulopathy | Q37772358 | ||
| Mesenteric embolization for lower gastrointestinal bleeding | Q37779692 | ||
| Optimal use of blood products in severely injured trauma patients | Q37829253 | ||
| An overview of embolic agents | Q37843506 | ||
| Evaluation of topical hemostatic agents for combat wound treatment | Q37879028 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Historical review of emergency tourniquet use to stop bleeding | Q37904111 | ||
| Lyophilized platelets: challenges and opportunities | Q37917501 | ||
| Thrombin use in surgery: an evidence-based review of its clinical use. | Q37979181 | ||
| Constant challenges and evolution of US military transfusion medicine and blood operations in combat | Q38009078 | ||
| Military medical revolution: prehospital combat casualty care. | Q38063372 | ||
| Battlefield trauma care then and now: a decade of Tactical Combat Casualty Care | Q38063376 | ||
| New fundamentals in hemostasis | Q38072904 | ||
| Challenges and promises for the development of donor-independent platelet transfusions | Q38074224 | ||
| An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis | Q38107909 | ||
| A platelet-inspired paradigm for nanomedicine targeted to multiple diseases | Q38145567 | ||
| Continuing education course #2: current understanding of hemostasis | Q35078025 | ||
| Blood component therapy: Which, when and how much | Q35079782 | ||
| Fibrin sealants: surgical hemostat, sealant and adhesive | Q35119682 | ||
| A profile of combat injury | Q35136408 | ||
| Review of new topical hemostatic dressings for combat casualty care | Q35164702 | ||
| Fibrin sealants in clinical practice | Q35180481 | ||
| Fibrin sealants in supporting surgical techniques: strength in factor XIII. | Q35180485 | ||
| Clinical application of soft polyglycolic acid felt for hemostasis and repair of a lacerated liver: report of two cases | Q80606554 | ||
| Cell-based models of coagulation: a paradigm in evolution | Q81142554 | ||
| Plasma-derived biological medicines used to promote haemostasis | Q81194578 | ||
| Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function | Q82064268 | ||
| Safety of Recombinant Activated Factor VII in Randomized Clinical Trials | Q82292902 | ||
| Comparison of Combat Gauze and TraumaStat in two severe groin injury models | Q82492858 | ||
| The performance of a hemostatic agent based on oxidized regenerated cellulose--polyglactin 910 composite in a liver defect model in immunocompetent and athymic rats | Q82845554 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-11-22 | |
| P1433 | published in | Advanced Materials | Q1085159 |
| P1476 | title | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding | |
| P478 | volume | 30 |
| Q64082006 | A tightly-bonded and flexible mesoporous zeolite-cotton hybrid hemostat |
| Q64283903 | Absorbable hemostatic hydrogels comprising composites of sacrificial templates and honeycomb-like nanofibrous mats of chitosan |
| Q64265776 | Cuboidal tethered cyclodextrin frameworks tailored for hemostasis and injured vessel targeting |
| Q90379562 | First-Line Interactive Wound Dressing Update: A Comprehensive Review of the Evidence |
| Q51740307 | Intravenous administration of synthetic platelets (SynthoPlateTM) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis. |
| Q49958847 | Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve 'golden hour' survival in a porcine model of traumatic arterial hemorrhage |
| Q60306460 | Nanotechnology-enabled materials for hemostatic and anti-infection treatments in orthopedic surgery |
| Q58735789 | Optimizing transfusion strategies in damage control resuscitation: current insights |
| Q91634716 | Platelet-Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury |
| Q92444987 | The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine |
| Q64891146 | Translation of bone wax and its substitutes: History, clinical status and future directions. |
Search more.